EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Imported chikungunya in French travellers returning from outbreak-affected regions

Eric Plennevaux, Adrianne De Roo, Guenaelle Augier, Gerard T Vonderling, Juan C Jaramillo

Journal of Travel Medicine · 2026-10-22

DOI: 10.1093/jtm/taag095 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Outbreaks of chikungunya disease are unpredictable, typically episodic and explosive. In 2025, several such outbreaks were observed and a marked increase in imported cases of chikungunya to mainland France was reported. This study aimed to describe the rate of chikungunya in French travellers returning from La Réunion, Mayotte, Mauritius, Madagascar, Sri Lanka and Cuba, all of which showed major chikungunya resurgences in 2025, and to assess the potential burden that the chikungunya virus outbreaks—whether officially notified or not—can cause to travellers. Methods Publicly available data from Santé Publique France were used to extract the number of chikungunya cases, and International Air Transport Association data were used for information on the number of flight tickets to estimate traveller numbers. These data were used to derive monthly rates of imported cases of chikungunya to mainland France from January to December 2025. Results Trends in rates of chikungunya amongst travellers returning to mainland France from La Réunion and Mayotte closely mirrored the sharp and compact epidemic curves observed locally. Peak imported rates exceeded 1800 cases/100 000 travellers (La Réunion [April]) and 400 cases/100 000 travellers (Mayotte [May]) and remained above 100 cases/100 000 travellers for March, April, May and June (La Réunion) and April, May and June (Mayotte). For Mauritius, Madagascar, Sri Lanka and Cuba, estimated peak rates were 248, 338, 90 and 2480 cases/100 000 travellers, respectively, although it was noted that some outbreaks were not officially notified or were reported late. Conclusions Returning travellers to mainland France from regions facing a chikungunya outbreak in 2025 showed a substantial burden of infection and gave rise to local spread of disease, highlighting the importance of robust surveillance systems and timely outbreak notification.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →